Ensure normal inflammatory markers (CRP, ESR) to differentiate from rheumatoid or inflammatory arthropathies. 17. Osteoporosis
SOP-CLIN-020 Version: 2026.1 Effective Date: May 31, 2026 Review Cycle: Annual 1. Purpose & Scope
Fatigue, weight gain, cold intolerance, dry skin, constipation, bradycardia, and delayed deep tendon reflex relaxation phase.
Indicated for severe dehydration, bloody stools (dysentery), high fever, or immunosuppression. Perform Stool Multiplex PCR panel (bacterial, viral, protozoal), Stool Culture, and Clostridioides difficile toxin assay if recent antibiotic exposure. sop for diagnosis of top 20 common diseases updated
Perform spirometry to document a post-bronchodilator FEV1 increase of > 12% and > 200 mL from baseline.
). Urine culture is indicated for recurrent or complicated cases. 13. Chronic Kidney Disease (CKD)
Order a basic metabolic panel (BMP), lipid profile, fasting glucose, and urinalysis (to check for microalbuminuria). Purpose & Scope Fatigue, weight gain, cold intolerance,
Verify the presence of either nausea/vomiting or photophobia and phonophobia during attacks.
Palpitations, lightheadedness, syncope, fatigue, or dyspnea; can present acutely as an ischemic stroke.
Clinical diagnosis based on classic symptoms and response to empirical acid-suppression therapy. Diagnostic Tools & Labs: For all others
Rheumatoid arthritis, gouty arthritis, septic arthritis, pseudogout. 13. Non-Specific Low Back Pain
Conformance with DSM-5-TR GAD criteria, resulting in clinically significant distress or impairment. Mandatory Workup:
The CDC and IDSA now explicitly recommend against testing children <3 years old due to low prevalence. For all others, use the updated Centor criteria (0-4 points), with a new threshold: Centor 4 requires no test – treat empirically.
Tachycardia, diaphoresis, tremors, hyperreflexia. Diagnostic Criteria: Met via the GAD-7 screening tool score ≥10is greater than or equal to 10 , along with DSM-5-TR symptom validation.
Primarily clinical based on symptom response to an empiric 2-week trial of standard-dose Proton Pump Inhibitors (PPIs).